Narayana Hrudayalaya , a leading Indian healthcare provider, has taken a significant step in its international expansion strategy. The company's wholly-owned subsidiary, Health City Cayman Islands Ltd. (HCCI), has established a new entity in the United Kingdom, marking a notable development in the organization's global presence.

Key Highlights

• Narayana Hrudayalaya's subsidiary HCCI has incorporated Narayana Hrudayalaya UK Ltd. in the United Kingdom.
• The new entity was registered on October 8, 2025, as a private limited company under the UK Companies Act, 2006.
• This move establishes Narayana Hrudayalaya UK Ltd. as a wholly-owned step-down overseas subsidiary of Narayana Hrudayalaya Limited.

Corporate Structure and Financial Details

Strategic Implications

The incorporation of Narayana Hrudayalaya UK Ltd. appears to be a strategic move aimed at facilitating potential investments outside the Cayman Islands. While the new entity is currently established as a holding company, it positions Narayana Hrudayalaya to explore opportunities in the UK and potentially other European markets.

This development aligns with the broader trend of Indian healthcare providers expanding their international presence. By establishing a foothold in the UK, Narayana Hrudayalaya may be looking to tap into new markets, diversify its operations, and potentially bring its healthcare model to a global audience.

Regulatory Compliance

The company has duly informed the stock exchanges about this development, in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This transparency ensures that shareholders and the market are kept informed about significant corporate actions that may impact the company's future operations and financial performance.

As Narayana Hrudayalaya continues to expand its global footprint, stakeholders will be keen to observe how this new UK subsidiary contributes to the company's overall growth strategy and international operations in the coming years.

Narayana Hrudayalaya , a leading healthcare provider, has reported mixed results for the first quarter, with strong performance in India operations offset by challenges in its Cayman Islands business.

India Operations Show Improvement

The company's India operations demonstrated improvement with expanded EBITDA margins. This growth was driven by:

• Better payor mix
• Higher-value procedures
• Price increases

The Average Length of Stay (ALOS) decreased from 4.5 to 4.3 days, indicating improved operational efficiency.

Cayman Islands: Growth and Challenges

Cayman Islands operations generated $45.00 million in revenue but faced challenges with EBITDA declining by INR 20.00-25.00 crores sequentially. This decline was primarily due to margin dilution from the new Integrated Care business. The company's new hospital in Cayman Islands has seen all services activated, with management expressing confidence in its growth trajectory.

Insurance and Integrated Care Initiatives

Narayana Hrudayalaya's insurance business, operating under the brand names Aditi and Arya, has shown promising growth. The company reported approximately 6,000 policyholders, with plans to expand its reach. The Integrated Care model in Cayman Islands is expected to reach breakeven in 1-2 years.

Expansion Plans and Capital Expenditure

The company announced significant expansion plans, including new hospitals in Bangalore, Kolkata, and Raipur by FY27-28. These expansions will be supported by a capital expenditure of INR 3,000.00 crores. Management indicated that about 80% of this amount would be financed through borrowings.

Digital Transformation and Operational Improvements

Narayana Hrudayalaya is focusing on digital transformation initiatives, including paperless hospitals and improved ICU systems. The company reported that 85% of patient documents have been digitalized, which is expected to improve operational efficiencies and patient care.

Financial Highlights

• Ayushman Bharat contributed less than half of the government schemes segment.
• The drop in Bangladesh revenue contributed to an increase in Average Revenue Per Patient (ARPP) due to its lower realization.

Oncology Growth and Future Outlook

The company's oncology operations are growing, with management targeting 20-25% of total revenue within five years. Narayana Hrudayalaya has also invested in a startup, Everhope Oncology, to expand its presence in chemotherapy centers.

Challenges and Opportunities

While the company faces challenges in its new ventures and international operations, management remains optimistic about future growth. The expansion plans and focus on high-value procedures are expected to drive revenue growth in the coming years.

As Narayana Hrudayalaya continues to navigate the complex healthcare landscape, its strategic initiatives in digital transformation, expansion, and diversification into insurance and integrated care models position it for potential long-term growth in both domestic and international markets.